Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3239490 | 1.00 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL7641965 | 1.00 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL26929232 | 1.00 | AKR1B1 (0.37) | AKR1B1LMNAL3MBTL1 | |
| Glycerin SCHEMBL1082405 | 0.94 | ALDH1A1 (0.35) | AKR1B1LMNA | |
| Glycerin SCHEMBL28369474 | 0.94 | ALDH1A1 (0.35) | AKR1B1LMNA | |
| Valeric Acid SCHEMBL28056175 | 0.82 | AKR1B1 (0.39) | AKR1B1LMNA | |
| SCHEMBL28258836 | 0.80 | AKR1B1 (0.39) | AKR1B1LMNAL3MBTL1 | |
| SCHEMBL3749152 | 0.80 | AKR1B1 (0.39) | AKR1B1LMNAL3MBTL1 | |
| Stearic Acid SCHEMBL22164061 | 0.80 | GPR84 (0.47) | AKR1B1LMNA | |
| Stearic Acid SCHEMBL31572019 | 0.80 | GPR84 (0.47) | AKR1B1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116459166-A | Skin whitening product for sensitive muscles and preparation method thereof | 上海科黛生物科技有限公司 | 2023-07-21 | — | — | CN | claimed |
| EP-3442494-B1 | 10-HYDROXYSTEARIC ACID COMPOSITIONS | DSM IP ASSETS BV (NL) | 2022-06-15 | — | — | EP | claimed |
| WO-2021069158-A1 | SUNSCREEN CONTAINING A NATURAL, FILM-FORMING POLYMER | BEIERSDORF AG (DE) | 2021-04-15 | — | — | WO | claimed |
| CN-112105351-A | Prebiotic compositions and methods for maintaining a healthy skin microbiota | 金伯利-克拉克环球有限公司 | 2020-12-18 | — | — | CN | claimed |
| CN-108120679-B | Kit for predicting susceptibility of children to caries | 北京大学口腔医学院 | 2020-11-10 | — | — | CN | claimed |
| EP-3727278-A1 | COSMETIC EMULSION COMPRISING 1,2-DECANEDIOL | Symrise AG (DE) | 2020-10-28 | — | — | EP | claimed |
| CN-108120679-A | A kind of kit for predicting whether children are susceptible to dental caries | 北京大学口腔医学院 | 2018-06-05 | — | — | CN | claimed |
| US-20170266289-A1 | TOPICAL FORMULATION | ABBVIE INC. (US) | 2017-09-21 | — | — | US | claimed |
| EP-3185852-A1 | TOPICAL FORMULATION | AbbVie Inc. (US) | 2017-07-05 | — | — | EP | claimed |
| CN-104232503-B | Bacillus shacheensis and application thereof | 四川大学 | 2017-01-25 | — | — | CN | claimed |
| US-20100047297-A1 | NANOCRYSTALS FOR USE IN TOPICAL COSMETIC FORMULATIONS AND METHOD OF PRODUCTION THEREOF | ABBOTT GMBH & CO. KG (DE) | 2010-02-25 | — | — | US | claimed |
| EP-1501938-B1 | ANALYSIS OF SUBSTRATE UTILIZATION BY ANIMAL OR PLANT CELLS | BIOLOG INC (US) | 2009-10-21 | — | — | EP | claimed |
| EP-2099420-A1 | NANOCRYSTALS FOR USE IN TOPICAL COSMETIC FORMULATIONS AND METHOD OF PRODUCTION THEREOF | Abbott GmbH & Co. KG (DE) | 2009-09-16 | — | — | EP | claimed |
| CN-101469340-A | Identification plate for gram positive aerobic bacteria and preparation thereof | SHANGHAI FOSUN BIOLOG BIOTECH (CN) | 2009-07-01 | — | — | CN | claimed |
| WO-2008058755-A1 | NANOCRYSTALS FOR USE IN TOPICAL COSMETIC FORMULATIONS AND METHOD OF PRODUCTION THEREOF | ABBOTT GMBH & CO. KG (DE) | 2008-05-22 | — | — | WO | claimed |
| EP-1501938-A4 | COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS | BIOLOG INC (US) | 2007-01-03 | — | — | EP | claimed |
| EP-0845259-B1 | Stable sunscreening compositions containing surface active glucose derivatives and water soluble UV-filters | BEIERSDORF AG (DE) | 2006-03-22 | — | — | EP | claimed |
| EP-1501938-A2 | COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS | BIOLOG, INC. (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003089652-A2 | COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS | BIOLOG, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-20030162164-A1 | Comparative phenotype analysis of cells, including testing of biologically active compounds | BIOLOG, INC. | 2003-08-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170266289-A1 | TOPICAL FORMULATION | TSLP, CYP51A1, CYP17A1 | AKR1B1 151/4885LMNA 2996/4885L3MBTL1 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.